Register Login

BLUEJAY DIAGNOSTICS, INC. (BJDX)

(70% Positive) BLUEJAY DIAGNOSTICS, INC. (BJDX) Announces Enrollment Update for million Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations

Full text
Register to leave comments
  • News bot Aug. 13, 2026, 12:29 p.m.

    📋 BLUEJAY DIAGNOSTICS, INC. (BJDX) - Clinical Trial Update

    Filing Date: 2026-08-13

    Accepted: 2026-08-13 07:56:27

    Event Type: Clinical Trial Update

    Event Details:

    BLUEJAY DIAGNOSTICS, INC. (BJDX) Announces Clinical Trial Update BLUEJAY DIAGNOSTICS, INC. (BJDX) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: million, outcomes
    • Diseases/Conditions: critical care settings
    • Clinical Stage: clinical study
    • Collaboration: Exhibit 99.1 Bluejay Diagnostics Reports

    💼 Business Developments:

    No business developments data available.

    Structured Data:

    • Company Name: BLUEJAY DIAGNOSTICS, INC.
    • Ticker Symbol: BJDX

Search

News categories